NCT01152138

Brief Summary

The aim of this study is to determine whether a closed cell stent design may reduce distal embolization and no reflow during primary percutaneous coronary intervention (PPCI) for acute ST-elevation acute myocardial infarction (STEMI) compared to an open cell stent design. The study population will include all consecutive patients admitted for acute STEMI and treated with PPCI within 12 hours from symptom onset.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 29, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

May 17, 2012

Status Verified

May 1, 2012

Enrollment Period

1.8 years

First QC Date

June 25, 2010

Last Update Submit

May 16, 2012

Conditions

Keywords

Acute myocardial infarctionClosed cell stentOpen cell stentprimary percutaneous coronary intervention

Outcome Measures

Primary Outcomes (1)

  • Post procedural angiographic evaluation

    The corrected Thrombolysis In Myocardial Infarction (TIMI) frame count at the end of the procedure defined as the number of frames required to opacify angiographic landmarks and normalized for vessel length and a composite end-point including angiographic events such as distal embolization, slow-flow (decrease in flow from TIMI 3 to TIMI 2) or no-reflow (decrease from TIMI 2 or 3 to TIMI 0 or 1) and a binary electrocardiographic criterion of microvascular injury as defined by the presence of persistent (\>50% of initial value) ST-segment elevation 30-60 min after procedure

    whithin 1 day

Secondary Outcomes (1)

  • Post stent angiographic results and in hospital MACE

    whithin 7 days

Study Arms (2)

Open Cell Stent

ACTIVE COMPARATOR

Open cell stent (Driver™ or Integrity™,Medtronic), routinely employed during percutaneous coronary interventions for ST elevation acute myocardial infarction

Device: Open cells stent

Closed Cell Stent

ACTIVE COMPARATOR

Closed cell stent (Presillion Plus™, Cordis), routinely employed during percutaneous coronary interventions for ST elevation acute myocardial infarction

Device: Closed Cells Stent

Interventions

Cobalt Chromium Stent with open cell design

Also known as: Driver Stent, Medtronic, Integrity Stent, Medtronic
Open Cell Stent

Cobalt Chromium stent with closed cell design

Also known as: Presillion Plus Stent, Cordis
Closed Cell Stent

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with an age \> 18 years with acute ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PPCI) within 12 hours from symptom onset and who agree and provide written informed consent. STEMI is defined as chest pain associated with ST-elevation of 1 mm or more in two or more contiguous leads or new left bundle-branch block within 12 hours after the onset of chest pain

You may not qualify if:

  • implanted stent with diameter \< 2.5 mm
  • cardiogenic shock
  • time from pain onset to PPCI \>12 hours
  • previous thrombolytic therapy (rescue PPCI)
  • inability to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UOC Cardiologia - Policlinico Casilino - ASL RMB

Rome, Italy

Location

UOC Cardiologia - Ospedale Belcolle

Viterbo, Italy

Location

MeSH Terms

Interventions

Stents

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and Supplies

Study Officials

  • Alessandro Sciahbasi, MD

    Policilnico Casilino - ASL RMB

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

June 25, 2010

First Posted

June 29, 2010

Study Start

March 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

May 17, 2012

Record last verified: 2012-05

Locations